Lei Yuan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Lei Yuan has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Bowen Xie
Institute for Immunology, Tsinghua University, Beijing, China
2 shared publications - Chen Dong
Westlake University School of Medicine, Hangzhou, China
2 shared publications - Xiaohu Wang
Institute for Immunology, Tsinghua University, Beijing, China
2 shared publications - Yongzhen Chen
Institute for Immunology, Tsinghua University, Beijing, China
2 shared publications - Zixuan Zhao
Institute for Immunology, Tsinghua University, Beijing, China
2 shared publications Birui Pan
Institute for Immunology, Tsinghua University, Beijing, China
1 shared publication
Latest Publications
- 31 July 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Immunology
- Vol. 11 (121)
Dynamic expression of IL-21 in effector CD8 T cells helps control chronic infections
CD8 T cells are critical players in immune responses against pathogens. Interleukin-21 (IL-21) is predominantly produced by CD4 T cells and exerts multifaceted effects on CD8 T cell regulation and function. Using Il21 -reporter and Il21 –fate mapping mice, we report that a subpopulation of activated CD8 T cells also produces IL-21 in the context of lymphocytic choriomeningitis virus (LCMV) infection. During the early effector phase of both acute and chronic infections, IL-21–expressing CD8 T cells exhibit substantial proliferative and cytotoxic capacities, with higher levels of interferon-γ (IFN-γ) and granzyme B (GZMB) compared with IL-21 − counterparts. Moreover, CD8 T cell–derived IL-21 played a critical protective role in chronic, but not acute, infection. IL-21 expression in CD8 T cells appeared to be largely restricted to exhausted progenitor T cells during the exhaustion phase of chronic infection. These findings identify IL-21–expressing CD8 T cells as pivotal players in the control of chronic infection.
- 31 July 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Immunology
- Vol. 11 (121)
Dynamic expression of IL-21 in effector CD8 T cells helps control chronic infections
CD8 T cells are critical players in immune responses against pathogens. Interleukin-21 (IL-21) is predominantly produced by CD4 T cells and exerts multifaceted effects on CD8 T cell regulation and function. Using Il21 -reporter and Il21 –fate mapping mice, we report that a subpopulation of activated CD8 T cells also produces IL-21 in the context of lymphocytic choriomeningitis virus (LCMV) infection. During the early effector phase of both acute and chronic infections, IL-21–expressing CD8 T cells exhibit substantial proliferative and cytotoxic capacities, with higher levels of interferon-γ (IFN-γ) and granzyme B (GZMB) compared with IL-21 − counterparts. Moreover, CD8 T cell–derived IL-21 played a critical protective role in chronic, but not acute, infection. IL-21 expression in CD8 T cells appeared to be largely restricted to exhausted progenitor T cells during the exhaustion phase of chronic infection. These findings identify IL-21–expressing CD8 T cells as pivotal players in the control of chronic infection.
- 5 August 2025
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 222 (10)
Ciliated cell–derived IL-17D restrains allergic asthma through controlling monocyte recruitment
The airway epithelium plays a crucial role in maintaining lung homeostasis, and its dysregulation is often linked to various lung diseases, including asthma. Ciliated cells, abundantly present in the mammalian airway epithelium, have a critical function in clearing inhaled particles and pathogens. We show here that ciliated cells constitutively express IL-17D, which functions as an immune brake in limiting allergic inflammation in murine models of asthma. Mechanistically, IL-17D functions to prevent influx of classical monocytes into the lung and their subsequent conversion to pathogenic alveolar macrophages, through binding to CD93. Deficiency in Il17d or Cd93 increased the expression of chemokine receptors on classical monocytes, including CCR6, thereby enhancing their recruitment to the lung and type 2 inflammation. Our study thus reveals an unexpected protective role of ciliated cells and IL-17D in lung immune responses and asthma, which can be further explored for treating related diseases.
- 5 August 2025
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 222 (10)
Ciliated cell–derived IL-17D restrains allergic asthma through controlling monocyte recruitment
The airway epithelium plays a crucial role in maintaining lung homeostasis, and its dysregulation is often linked to various lung diseases, including asthma. Ciliated cells, abundantly present in the mammalian airway epithelium, have a critical function in clearing inhaled particles and pathogens. We show here that ciliated cells constitutively express IL-17D, which functions as an immune brake in limiting allergic inflammation in murine models of asthma. Mechanistically, IL-17D functions to prevent influx of classical monocytes into the lung and their subsequent conversion to pathogenic alveolar macrophages, through binding to CD93. Deficiency in Il17d or Cd93 increased the expression of chemokine receptors on classical monocytes, including CCR6, thereby enhancing their recruitment to the lung and type 2 inflammation. Our study thus reveals an unexpected protective role of ciliated cells and IL-17D in lung immune responses and asthma, which can be further explored for treating related diseases.